glp 1 receptor agonist weight loss GLP-1 Agonists as Treatments for Type 2 Diabetes Frontiers | GLP−1 receptor agonists

Description

How is that even possible

The GIP receptor agonism complements GLP-1 receptor activation by enhancing glucose-dependent insulin secretion, thereby improving glycemic control and weight loss more effectively than GLP-1RAs alone

GorgojoMartnez JJ, GargalloFernandez MA, BritoSanfiel M, LisbonaCatalan A

Harsha Varma S, Tirupati S, Pradeep TVS, et al

Taking into account the above-mentioned considerations on cost and safety aspects, oral small molecule agonists stimulating endogenous GLP-1 secretion by intestinal L-cells may offer a promising alternative for developing new treatments for Type 2 diabetes and obesity